1. Home
  2. IMMR vs XGN Comparison

IMMR vs XGN Comparison

Compare IMMR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.44

Market Cap

229.4M

Sector

Technology

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$6.43

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
XGN
Founded
1993
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.4M
253.9M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
IMMR
XGN
Price
$6.44
$6.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$12.25
$13.67
AVG Volume (30 Days)
689.7K
246.3K
Earning Date
12-19-2025
11-04-2025
Dividend Yield
4.65%
N/A
EPS Growth
57.07
N/A
EPS
2.04
N/A
Revenue
$163,133,000.00
$63,599,000.00
Revenue This Year
$988.71
$22.15
Revenue Next Year
$109.72
$15.26
P/E Ratio
$3.16
N/A
Revenue Growth
338.21
14.08
52 Week Low
$5.65
$2.67
52 Week High
$9.37
$12.23

Technical Indicators

Market Signals
Indicator
IMMR
XGN
Relative Strength Index (RSI) 42.03 24.04
Support Level $6.42 $6.37
Resistance Level $7.09 $7.29
Average True Range (ATR) 0.19 0.34
MACD -0.04 0.03
Stochastic Oscillator 6.16 1.63

Price Performance

Historical Comparison
IMMR
XGN

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: